Search clinical trials for: AMG 655

Total 1925 results

Novartis Pharmaceuticals

Completed

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Astrocytoma | Glioblastoma Multiforme

Germany
Amgen

Terminated

An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial

Heart Failure | Cardiovascular Disease | Anemia | Ventricular Dysfunction | Congestive Heart Failure
Rockefeller University
Amgen

Completed

Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis

Psoriasis

United States
Amgen

Completed

A Research Study for Patients With End-Stage Renal Disease (ESRD)

End Stage Renal Disease
Lymphoma Study Association
Amgen

Completed

ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

Diffuse Large-Cell Lymphoma

France, Belgium
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; Baxter Healthcare Corporation; Amgen

Completed

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

Testicular Neoplasms

France
Amgen

Completed

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates

Bone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Amgen

Completed

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.

Osteoporosis | Osteopenia
Amgen

Completed

A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid

Myelodysplastic Syndromes | Thrombocytopenia
Amgen

Completed

A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate

Rheumatoid Arthritis
Amgen
Immunex Corporation

Completed

Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders

Rheumatoid Arthritis
Amgen

Completed

Study to Evaluate Effectiveness of Aranesp®

Kidney Disease
Amgen

Completed

Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis

Chronic Kidney Disease
Amgen

Completed

A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors

Histologically or Cytologically Documented Solid Tumors
Amgen

Completed

Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors

Solid Tumors
Amgen

Completed

Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

Kidney Transplantation
Amgen

Completed

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

Colorectal Cancer
University Hospital, Clermont-Ferrand
Amgen

Unknown

Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5) (MEG-5)

Solid Malignancies

France
Seoul National University Hospital
Green Cross Corporation

Completed

Pharmacokinetics and Pharmacodynamics of a Novel Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor (GCPGC)

Healthy

Korea, Republic of
Amgen

Completed

Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects

Healthy Volunteers
Amgen

Completed

Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis

Postmenopausal Osteoporosis
Amgen
Immunex Corporation

Completed

Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis

Psoriasis | Psoriatic Arthritis
Amgen

Completed

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

Neutropenia
Amgen

Completed

Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia

Anemia | Congestive Heart Failure
Massachusetts General Hospital
Amgen

Completed

Study of TNF-Antagonism in the Metabolic Syndrome (II)

Metabolic Syndrome

United States
Austin Health

Unknown

Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer (Vengeance)

Metastatic Colorectal Cancer

Australia
Associacio catalana per a la recerca oncologica...
Amgen

Unknown

A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy (ACTIVE)

Metastatic Colorectal Cancer

Spain
Amgen

Completed

ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Neoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer
Amgen

Completed

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Breast Cancer | Non-Hodgkin's Lymphoma | Ovarian Cancer | Lung Cancer | Neutropenia
Amgen

Completed

Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors

Tumors
Amgen
Immunex Corporation

Completed

Enbrel Liquid Immunogenicity Protocol

Rheumatoid Arthritis
U3 Pharma GmbH

Completed

Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Amgen

Completed

Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology

Idiopathic Thrombocytopenic Purpura
Centre Leon Berard
Amgen

Completed

Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma (PALM)

Lymphoma | Myeloma

France
National University Hospital, Singapore
National University of Singapore

Completed

A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach (CAFBI)

Gastric Cancer
University of California, San Diego
Amgen

Unknown

Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis

Inflammation | Obesity | Psoriasis | Cardiovascular Risk

United States
Florida Academic Dermatology Centers
Amgen

Unknown

An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use (ENBRECAP2009)

Psoriasis

United States
Amgen

Completed

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

End Stage Renal Disease
Amgen

Completed

A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women

Osteopenia
Radboud University Medical Center
Sanofi; Amgen

Completed

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. (INTENS)

Breast Cancer

Netherlands
Groupe Français de Pneumo-Cancérologie
Baxter Healthcare Corporation; Amgen

Unknown

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

France
Amgen

Completed

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Cancer | Anemia | Non-Myeloid Malignancies
Amgen

Completed

A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis
Amgen

Completed

STAAR-2 Clinical Study

Chronic Kidney Disease | Chronic Renal Insufficiency | Kidney Disease | Pre-dialysis | Pre-ESRD
Swedish Medical Center
Bayer; Amgen

Completed

Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

Lung Cancer

United States
Amgen

Completed

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Sarcoma | Neutropenia
Amgen

Completed

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Breast Cancer
Amgen

Completed

Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis

Nephrology
Amgen

Completed

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Breast Cancer
Amgen
Medtronic

Completed

Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin

Parkinson's Disease

3

Subscribe